Cargando…
High expression of the vacuole membrane protein 1 (VMP1) is a potential marker of poor prognosis in HER2 positive breast cancer
BACKGROUND: Fusion genes result from genomic structural changes, which can lead to alterations in gene expression that supports tumor development. The aim of the study was to use fusion genes as a tool to identify new breast cancer (BC) genes with a role in BC progression. METHODS: Fusion genes from...
Autores principales: | Amirfallah, Arsalan, Arason, Adalgeir, Einarsson, Hjorleifur, Gudmundsdottir, Eydis Thorunn, Freysteinsdottir, Edda Sigridur, Olafsdottir, Kristrun Audur, Johannsson, Oskar Thor, Agnarsson, Bjarni Agnar, Barkardottir, Rosa Bjork, Reynisdottir, Inga |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707546/ https://www.ncbi.nlm.nih.gov/pubmed/31442252 http://dx.doi.org/10.1371/journal.pone.0221413 |
Ejemplares similares
-
Hsa-miR-21-3p associates with breast cancer patient survival and targets genes in tumor suppressive pathways
por: Amirfallah, Arsalan, et al.
Publicado: (2021) -
The risk allele of SNP rs3803662 and the mRNA level of its closest genes TOX3 and LOC643714 predict adverse outcome for breast cancer patients
por: Gudmundsdottir, Eydis Th, et al.
Publicado: (2012) -
High Atlastin 2-2 (ATL2-2) Expression Associates with Worse Prognosis in Estrogen-Receptor-Positive Breast Cancer
por: Reynisdottir, Inga, et al.
Publicado: (2023) -
The BRCA1 c.4096+3A>G Variant Displays Classical Characteristics of Pathogenic BRCA1 Mutations in Hereditary Breast and Ovarian Cancers, But Still Allows Homozygous Viability
por: Arason, Adalgeir, et al.
Publicado: (2019) -
High expression of ZNF703 independent of amplification indicates worse prognosis in patients with luminal B breast cancer
por: Reynisdottir, Inga, et al.
Publicado: (2013)